CryoTherapeutics, a medical device company developing minimally invasive localized cryotherapy for the treatment of coronary artery disease, today announced the successful treatment of the first ...
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company"), the leading autologous (patient's own stem cells) regenerative medicine company is pleased to announce that it has filed its ...
Percutaneous coronary intervention for coronary chronic total occlusion is associated with a significant improvement in angina symptom scores compared with a placebo procedure. Percutaneous coronary ...
Percutaneous coronary intervention (PCI) significantly reduces angina frequency in patients with stable coronary artery disease regardless of their age. A secondary analysis of clinical trial data ...
ORBITA-2 (the Placebo-Controlled Trial of Percutaneous Coronary Intervention for the Relief of Stable Angina) provided evidence for the role of percutaneous coronary intervention (PCI) for angina ...
PARIS — After the first major prospective study to associate percutaneous intervention (PCI) with symptom relief in stable angina captured international attention, a new analysis of the ...
Study Rundown: Angina is often one of the first discernible symptoms of underlying coronary artery disease. Stable angina is characterized by chest discomfort that is triggered by stress or exertion ...
Stents are like scaffolding that keep narrowed arteries open. These devices have been revolutionary in treating heart attacks, where their use has increased year on year, and countless lives have been ...
Some patients with chest pain from reduced blood flow to the heart may benefit from having a stent implanted, instead of chest pain medications. These are the findings of a study, led by researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results